UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

Nature communications, 2017-08, Vol.8 (1), p.268-11, Article 268

2017

Volltextzugriff (PDF)

Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents

Haematologica (Roma), 2012-11, Vol.97 (11), p.1761-1767

2012

Volltextzugriff (PDF)

Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia

Blood, 2000, Vol.95 (1), p.67-71

2000

Volltextzugriff (PDF)

Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma

The New England journal of medicine, 2006-03, Vol.354 (10), p.1021-1030

2006

Volltextzugriff (PDF)

Highly activated and expanded natural killer cells for multiple myeloma immunotherapy

Haematologica (Roma), 2012-09, Vol.97 (9), p.1348-1356

2012

Volltextzugriff (PDF)

P1140: TIME TO TUMOR, SYMPTOMATIC AND LABORATORY RESPONSES FOLLOWING SILTUXIMAB TREATMENT IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE

HemaSphere, 2022-06, Vol.6 (Suppl), p.1030-1031

2022

Volltextzugriff (PDF)

Human γδ+ T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic response

Bone marrow transplantation (Basingstoke), 2001-03, Vol.27 (6), p.601-606

2001

Volltextzugriff (PDF)

P925: IMPACT OF PRIOR TREATMENT EXPOSURE ON THE EFFECTIVENESS OF IXAZOMIB‐LENALIDOMIDE‐DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED IN ROUTINE CLINICAL PRACTICE (THE INSURE STUDY)

HemaSphere, 2022-06, Vol.6 (Suppl), p.815-816

2022

Volltextzugriff (PDF)

Adoptive transfer of Ag-specific T cells to prevent CMV disease after allogeneic stem-cell transplantation

Cytotherapy (Oxford, England), 2002-01, Vol.4 (1), p.3-10

2002

Volltextzugriff (PDF)

Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma

Haematologica (Roma), 2013-07, Vol.98 (7), p.1147-1153

2013

Volltextzugriff (PDF)

Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia

Blood, 2000-01, Vol.95 (1), p.67-71

2000

Volltextzugriff (PDF)

P.2.b.033 Siltuximab improves depressive symptoms in a randomised, placebo-controlled, phase 2 study in patients with multicentric Castlemen's disease

European neuropsychopharmacology, 2015-09, Vol.25, p.S403-S404

2015

Volltextzugriff (PDF)

Jumping Translocations of 1q12 in Multiple Myeloma: Unexpected Intra-clonal Heterogeneity of Copy Number Aberrations in the 1q21-31 Region

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e47-e47

2015

Volltextzugriff (PDF)

Can we cure Multiple Myeloma by 2020? Yes

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e36-e36

2015

Volltextzugriff (PDF)

Idiopathic multicentric Castleman's disease: a systematic literature review

The Lancet. Haematology, 2016-04, Vol.3 (4), p.e163-e175

2016

Volltextzugriff (PDF)

CD4+ bias in T cells cloned from a CML patient with active graft versus leukemia effect

Cytotherapy (Oxford, England), 2002-07, Vol.4 (4), p.353-363

2002

Volltextzugriff (PDF)

Treatment advances in multiple myeloma

British journal of haematology, 2004-04, Vol.125 (1), p.24-30

2004

Volltextzugriff (PDF)

p190 BCR-ABL mRNA Is Expressed at Low Levels in p210-Positive Chronic Myeloid and Acute Lymphoblastic Leukemias

Blood, 1996-06, Vol.87 (12), p.5213-5217

1996

Volltextzugriff (PDF)

Standard and novel imaging methods for multiple myeloma: correlates with prognostic laboratory variables including gene expression profiling data

Haematologica (Roma), 2013-01, Vol.98 (1), p.71-78

2013

Volltextzugriff (PDF)

Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120)

Haematologica (Roma), 2015-09, Vol.100 (9), p.1214-1221

2015

Volltextzugriff (PDF)

Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation

British journal of haematology, 2004-09, Vol.126 (5), p.715-721

2004

Volltextzugriff (PDF)

Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells

Blood, 2002-03, Vol.99 (5), p.1745-1757

2002

Volltextzugriff (PDF)

NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses

Blood, 2005-05, Vol.105 (10), p.3939-3944

2005

Volltextzugriff (PDF)

Specific depletion of alloreactive T cells in HLA‐identical siblings: a method for separating graft‐versus‐host and graft‐versus‐leukaemia reactions

British journal of haematology, 1998-06, Vol.101 (3), p.565-570

1998

Volltextzugriff (PDF)

1 – 25 von 257

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(240)
Mit Volltextzugriff
(234)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(117)
Life Sciences & Biomedicine
(93)
Humans
(92)
Biological And Medical Sciences
(55)
Medical Sciences
(50)
Hematology
(42)
Male
(41)
Female
(39)
Middle Aged
(32)
Adult
(29)
Aged
(21)
Physical Sciences
(20)
Adolescent
(13)
Hematologic And Hematopoietic Diseases
(13)
Immunopathology
(13)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Therapy
(13)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(12)
Immunodeficiencies. Immunoglobulinopathies
(12)
Mutation
(12)
Prognosis
(12)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(28)
Journal Of Clinical Oncology
(25)
British Journal Of Haematology
(15)
Neophilologus
(13)
Amsterdamer Beiträge Zur Älteren Germanistik
(10)
Bone Marrow Transplantation
(8)
Haematologica
(7)
Cytotherapy
(5)
Experimental Hematology
(5)
Hemasphere
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents

Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia

Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma

Highly activated and expanded natural killer cells for multiple myeloma immunotherapy

P1140: TIME TO TUMOR, SYMPTOMATIC AND LABORATORY RESPONSES FOLLOWING SILTUXIMAB TREATMENT IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE

Human γδ+ T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic response

P925: IMPACT OF PRIOR TREATMENT EXPOSURE ON THE EFFECTIVENESS OF IXAZOMIB‐LENALIDOMIDE‐DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED IN ROUTINE CLINICAL PRACTICE (THE INSURE STUDY)

Adoptive transfer of Ag-specific T cells to prevent CMV disease after allogeneic stem-cell transplantation

Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma

Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia

P.2.b.033 Siltuximab improves depressive symptoms in a randomised, placebo-controlled, phase 2 study in patients with multicentric Castlemen's disease

Jumping Translocations of 1q12 in Multiple Myeloma: Unexpected Intra-clonal Heterogeneity of Copy Number Aberrations in the 1q21-31 Region

Can we cure Multiple Myeloma by 2020? Yes

Idiopathic multicentric Castleman's disease: a systematic literature review

CD4+ bias in T cells cloned from a CML patient with active graft versus leukemia effect

Treatment advances in multiple myeloma

p190 BCR-ABL mRNA Is Expressed at Low Levels in p210-Positive Chronic Myeloid and Acute Lymphoblastic Leukemias

Standard and novel imaging methods for multiple myeloma: correlates with prognostic laboratory variables including gene expression profiling data

Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120)

The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtype

Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation

Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells

NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses

Specific depletion of alloreactive T cells in HLA‐identical siblings: a method for separating graft‐versus‐host and graft‐versus‐leukaemia reactions

Aktive Filter

Suchergebnisse filtern